Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized Study Aiming to Assess the Benefit of Autohypnosis Learning in the Care of Patients Treated by Adjuvant Chemotherapy for Colorectal or Breast Cancer.

NCT03429296 is registered in ClinicalTrials.gov with Groupe Hospitalier Mutualiste de Grenoble as lead sponsor.

NCT NCT03429296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03429296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized Study Aiming to Assess the Benefit of Autohypnosis Learning in the Care of Patients Treated by Adjuvant Chemotherapy for Colorectal or Breast Cancer.
Lead sponsor
Groupe Hospitalier Mutualiste de Grenoble
Phase
Not applicable
Overall status
Completed
Start date
May 23, 2018
Completion date
July 1, 2022
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colorectal cancer